Radicava
NDC Package 70510-2171-2
Package Information
Radicava is edaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). Marketed by Shionogi Inc., this product is identified by NDC 70510-2171 and is authorized under FDA application NDA209176.
Identification & Billing
- RxCUI: 1924316 - edaravone 30 MG in 100 ML Injection
- RxCUI: 1924316 - 100 ML edaravone 0.3 MG/ML Injection
- RxCUI: 1924316 - edaravone 30 MG per 100 ML Injection
- RxCUI: 1924317 - Radicava 30 MG in 100 ML Injection
- RxCUI: 1924317 - 100 ML edaravone 0.3 MG/ML Injection [Radicava]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70510 - Shionogi Inc.
- 70510-2171 - Radicava
- 70510-2171-2 - 2 BAG in 1 CARTON / 100 mL in 1 BAG (70510-2171-1)
- 70510-2171 - Radicava
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70510-2171-2 identifies a specific commercial package of 2 bag in 1 carton / 100 ml in 1 bag (70510-2171-1) of Radicava, labeled by Shionogi Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Shionogi Inc. on May 05, 2017. The current certification is valid through January 31, 2026.
What are the primary indications for this medication?
Edaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). It helps to slow down the worsening of this disease. However, it is not a cure for ALS, and it does not reverse nerve damage or muscle weakness.
How is this Shionogi Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70510217102. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
